Puerto Rico · J7324

Hyaluronan Or Derivative, Orthovisc, For Intra-Articular Injection, Per Dose in Puerto Rico

Puerto Rico Medicare Avg
$92.84
5% below national avg
National Medicare Avg
$98.22
All states combined
Billed Charge (PR)
$211.34
What providers submit
Est. Commercial (PR)
$268.82
National avg: $280.88
Est. Cash / Self-Pay (PR)
$148.13
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

128
Services in PR
7
Providers
N/A
Min Payment
N/A
Max Payment

Puerto Rico Pricing in Context

In Puerto Rico, CPT code J7324 (Hyaluronan Or Derivative, Orthovisc, For Intra-Articular Injection, Per Dose) carries an average Medicare payment of $92.84 — 5% below the national benchmark of $98.22. 7 providers across the state submitted claims for this procedure in 2023, performing 128 total services. Individual payments in PR ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Puerto Rico is $211.34, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Puerto Rico sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Drugs (Administered) procedures, the estimated commercial insurance price in Puerto Rico lands near $268.82, with self-pay cash prices typically around $148.13. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Hyaluronan Or Derivative, Orthovisc, For Intra-Articular Injection, Per Dose cost in Puerto Rico?

The average Medicare payment for Hyaluronan Or Derivative, Orthovisc, For Intra-Articular Injection, Per Dose in Puerto Rico is $92.84, which is 5% below the national average of $98.22. Providers in PR typically bill $211.34 for this procedure.

What does Hyaluronan Or Derivative, Orthovisc, For Intra-Articular Injection, Per Dose cost with insurance in Puerto Rico?

With commercial insurance in Puerto Rico, Hyaluronan Or Derivative, Orthovisc, For Intra-Articular Injection, Per Dose costs an estimated $268.82. Without insurance, the estimated cash price is $148.13. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Hyaluronan Or Derivative, Orthovisc, For Intra-Articular Injection, Per Dose in Puerto Rico?

7 providers in Puerto Rico billed Medicare for Hyaluronan Or Derivative, Orthovisc, For Intra-Articular Injection, Per Dose in 2023, performing 128 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Hyaluronan Or Derivative, Orthovisc, For Intra-Articular Injection, Per Dose cheaper in Puerto Rico than the national average?

Yes — Hyaluronan Or Derivative, Orthovisc, For Intra-Articular Injection, Per Dose costs 5% below the national average in Puerto Rico. The state average Medicare payment is $92.84 compared to $98.22 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial